Research graph
References from Single-cell sequencing reveals shared clonal signatures in nonmalignant B and tumor cells in T-prolymphocytic leukemia. Local targets link to admitted publications; unresolved targets remain external evidence.
T-cell prolymphocytic leukemia: epidemiology and survival trends in the era of novel treatments
10.1002/ajh.27205 · 2024 · External reference
Advances in cellular therapy for T-cell prolymphocytic leukemia
10.3389/fonc.2022.781479 · 2022 · External reference
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia
10.1182/blood.2019000402 · 2019 · External reference
Long-smoldering T-prolymphocytic leukemia: a case report and a review of the literature
10.3390/curroncol30110727 · 2023 · External reference
Outcomes of allogeneic hematopoietic cell transplantation in T cell prolymphocytic leukemia: a contemporary analysis from the Center for International Blood and Marrow Transplant Research
10.1016/j.jtct.2022.01.017 · 2022 · External reference
Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia
10.1002/ajh.26918 · 2023 · External reference
Novel precision medicine approaches and treatment strategies in hematological malignancies
10.1111/joim.13697 · 2023 · External reference
JAK/STAT-activating genomic alterations are a hallmark of T-PLL
10.3390/cancers11121833 · 2019 · External reference
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study
10.1182/bloodadvances.2023012248 · 2024 · External reference
Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
10.1186/s12885-019-5529-0 · 2019 · External reference
Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
10.1002/ajh.25927 · 2020 · External reference
Somatic exonic deletions in RUNX1 constitutes a novel recurrent genomic abnormality in acute myeloid leukemia
10.1158/1078-0432.ccr-23-0122 · 2023 · External reference
How to manage patients with germline DDX41 variants: recommendations from the Nordic Working Group on germline predisposition for myeloid neoplasms
10.1002/hem3.145 · 2024 · External reference
Patient-specific measurable residual disease markers predict outcome in patients with myelodysplastic syndrome and related diseases after hematopoietic stem-cell transplantation
10.1200/jco.23.01159 · 2024 · External reference
Five percent variant allele frequency is a reliable reporting threshold for TP53 variants detected by next generation sequencing in chronic lymphocytic leukemia in the clinical setting
10.1097/hs9.0000000000000761 · 2022 · External reference
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
10.1038/s41467-017-02688-6 · 2018 · External reference
Genomics of resistance to targeted therapies
10.1016/j.hoc.2021.03.004 · 2021 · External reference
Evolutionary dynamics of chronic myeloid leukemia
10.1177/1947601910371122 · 2010 · External reference
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
10.1038/s41467-020-19119-8 · 2020 · External reference
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
10.1182/blood-2014-03-559542 · 2014 · External reference
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
10.1111/bjh.13952 · 2016 · External reference
Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and T-prolymphocytic leukemia presenting with lymphocytosis, skin lesions, and generalized lymphadenopathy
2019 · External reference
The incidence and gene frequency of ataxia-telangiectasia in the United States
1986 · External reference
Rare germline ATM variants of uncertain significance in chronic lymphocytic leukaemia and other cancers
10.1111/bjh.18419 · 2022 · External reference
